U2CCA271854
Cooperative Agreement
Overview
Grant Description
Michigan-VUMC Biomarker Characterization Center
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Ann Arbor,
Michigan
481082744
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 552% from $680,576 to $4,435,795.
Regents Of The University Of Michigan was awarded
Michigan-VUMC Biomarker Characterization Center
Cooperative Agreement U2CCA271854
worth $4,435,795
from National Cancer Institute in August 2022 with work to be completed primarily in Ann Arbor Michigan United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.394 Cancer Detection and Diagnosis Research.
The Cooperative Agreement was awarded through grant opportunity The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/5/26
Period of Performance
8/15/22
Start Date
7/31/27
End Date
Funding Split
$4.4M
Federal Obligation
$0.0
Non-Federal Obligation
$4.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U2CCA271854
Transaction History
Modifications to U2CCA271854
Additional Detail
Award ID FAIN
U2CCA271854
SAI Number
U2CCA271854-2115769455
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
GNJ7BBP73WE9
Awardee CAGE
03399
Performance District
MI-06
Senators
Debbie Stabenow
Gary Peters
Gary Peters
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,616,992 | 100% |
Modified: 8/5/26